Pharmafit Provence
CRISTAL Adult suppositories 10Sachet

Coopération Pharmaceutique Française

CRISTAL Adult suppositories 10Sachet

CIP / EAN code: 3400933195410

Product information from VIDAL.

Read the product information

Product information

Find indications, dosage and precautions in the sections below.

Automatic English translation of the French VIDAL document. Original numerical values and units are retained, including decimal commas.

VIDAL
Medicines
SmPC of 30/04/2014

CRISTAL ADULTS, suppository


Forms and presentations

Suppository.


Composition

Glycerol ........................................................................................................................................................................2,16 g

For a suppository of 3,6 g.


Excipients:

Gelatin, purified water.



Indications

  • Symptomatic treatment of low constipation, particularly due to rectal dyschezia.
  • Preparation for endoscopic examinations of the rectum.


Dosage and administration

Reserved for adults.

1 suppository 5 to 30 minutes before the time chosen for evacuation, to be repeated within half an hour or an hour afterward in case of stubborn constipation.

The treatment of constipation should not, on average, exceed 10 days.



Contraindications

History of hypersensitivity to glycerol or to any of the other constituents mentioned in the section Composition.



Warnings and precautions

Warnings

Prolonged use is not recommended.

Drug treatment of constipation is only an adjunct to hygienic-dietary treatment:

  • Enrichment of the diet with plant fibres and fluids;
  • Advice on physical activity and rehabilitation of evacuation.

Precautions for use

It is preferable not to use this medicine in cases of hemorrhoidal flare-ups, anal fissures, or hemorrhagic proctocolitis.



Interactions

The data available to date do not suggest the existence of clinically significant interactions.



Fertility, pregnancy and breastfeeding

In the absence of clinical data in pregnant or breastfeeding women, it is preferable not to take this medicine.



Adverse effects

A prolonged effect may give rise to anal burning sensations and, exceptionally, congestive proctitis.

Reporting of suspected adverse reactions

Reporting suspected adverse effects after authorisation of the medicinal product is important. It allows continuous monitoring of the benefit/risk balance of the medicinal product. Health professionals should report any suspected adverse effect via the national reporting system: National Agency for the Safety of Medicines and Health Products (ANSM) and the network of Regional Pharmacovigilance Centres. Website: www.ansm.sante.fr.



Overdose

No cases of overdose have been reported. However, in case of prolonged use, increased risk of proctitis and diarrhoea.



Pharmacodynamics

Pharmacotherapeutic class: OTHER LAXATIVES, ATC code A06AX01

(A: Alimentary tract and metabolism)

Rectal route.

Glycerin suppositories cause rapid evacuation of the rectosigmoid by triggering the defecation reflex. Defecation occurs within 5 to 30 minutes after administration.

Glycerol stimulates peristaltic movements and decreases water reabsorption through its osmotic and hygroscopic properties. It also has a local irritant effect that contributes to the reflex defecation.



Shelf life

3 years.



Special storage precautions

Store at a temperature not exceeding 25°C.



SPECIAL PRECAUTIONS FOR DISPOSAL AND OTHER HANDLING

No special requirements.



Prescription, supply and reimbursement

Marketing authorisation (AMM)
CIP 3400933195410 (10 Sach).
Not reimbursed by Social Security.

Coopération Pharmaceutique Française
PLACE LUCIEN AUVERT
77020 MELUN CEDEX
Tel: 01 64 87 20 00 https://www.cooper.fr/

Source: VIDAL · Updated on 10/11/2026. This information does not replace advice from a healthcare professional.